跳至主要内容
临床试验/ACTRN12611000955910
ACTRN12611000955910已完成不适用

Antilipolytic drug Acipimox during short-term exercise further increases plasma neuropeptide Y levels in patients with bulimia nervosa compared with healthy women: the role of lipolysis

Ministry of Health0 个研究点目标入组 16 人开始时间: 2011年9月6日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
16

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment

入排标准

年龄范围
18 Years 至 30 Years(—)
性别
Female

入选标准

  • age between 18 and 30 years, BMI between 18 and 23 kg/m2, patients with a diagnosis of bulimia nervosa (Diagnostic and Statistical Manual of Mental Disorders, DSM-IV, 1994)

排除标准

  • hypertension, abnormal blood tests with significant hyperlipidaemia, history or presence of hepatic or renal disorders
  • All eligible participants were deemed healthy.

研究者

相似试验